Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Date Action Amount Person Type
Dec 21, 2023 Buy 40 000 Bernstein Bruce Stock Option (Right to Buy)
Dec 21, 2023 Buy 54 533 Boctor Fady Stock Option (Right to Buy)
Dec 21, 2023 Buy 49 645 Boctor Fady Common Stock
Dec 21, 2023 Buy 40 000 Walker Wayne Remell Stock Option (Right to Buy)
Dec 21, 2023 Buy 20 000 Arnold Mitchell Stock Option (Right to Buy)
Dec 21, 2023 Buy 40 000 Silverman Joshua Stock Option (Right to Buy)
Dec 21, 2023 Buy 40 000 Bradley Greg Stock Option (Right to Buy)
Apr 26, 2023 Buy 6 050 Bradley Greg Common Stock
Apr 26, 2023 Sell 6 050 Bradley Greg Restricted Stock Units
Apr 26, 2023 Buy 6 050 Bernstein Bruce Common Stock
Apr 26, 2023 Sell 6 050 Bernstein Bruce Restricted Stock Units
Apr 26, 2023 Buy 6 050 Walker Wayne Remell Common Stock
Apr 26, 2023 Sell 6 050 Walker Wayne Remell Restricted Stock Units
Apr 26, 2023 Buy 6 722 Silverman Joshua Common Stock
Apr 26, 2023 Sell 6 722 Silverman Joshua Restricted Stock Units
Apr 10, 2023 Buy 39 000 Walker Wayne Remell Stock Option (Right to Buy)
Apr 10, 2023 Buy 39 000 Silverman Joshua Stock Option (Right to Buy)
Apr 10, 2023 Buy 39 000 Bradley Greg Stock Option (Right to Buy)
Apr 10, 2023 Buy 39 000 Bernstein Bruce Stock Option (Right to Buy)
Jan 20, 2023 Buy 2 264 Walker Wayne Remell Common Stock
Jan 20, 2023 Sell 2 264 Walker Wayne Remell Restricted Stock Units
Jan 20, 2023 Buy 2 515 Silverman Joshua Common Stock
Jan 20, 2023 Sell 2 515 Silverman Joshua Restricted Stock Units
Jan 20, 2023 Buy 2 264 Bradley Greg Common Stock
Jan 20, 2023 Sell 2 264 Bradley Greg Restricted Stock Units
Jan 20, 2023 Buy 2 264 Bernstein Bruce Common Stock
Jan 20, 2023 Sell 2 264 Bernstein Bruce Restricted Stock Units
Apr 07, 2022 Buy 60 505 Walker Wayne Remell Restricted Stock Units
Apr 07, 2022 Buy 67 227 Silverman Joshua Restricted Stock Units
Apr 07, 2022 Buy 60 505 Bradley Greg Restricted Stock Units
Apr 07, 2022 Buy 60 505 Bernstein Bruce Restricted Stock Units
Dec 22, 2021 Buy 22 642 Walker Wayne Remell Restricted Stock Units
Dec 22, 2021 Buy 25 156 Silverman Joshua Restricted Stock Units
Dec 22, 2021 Buy 22 642 Bradley Greg Restricted Stock Units
Dec 22, 2021 Buy 22 642 Bernstein Bruce Restricted Stock Units
Dec 22, 2021 Buy 145 773 Shulman John D Common Stock, par value $0.0001 per share
Dec 22, 2021 Buy 109 329 Shulman John D Warrant
Nov 29, 2021 Buy 500 000 Shulman John D Common Stock, par value $0.0001 per share
Nov 29, 2021 Buy 375 000 Shulman John D Warrant
Oct 18, 2021 Buy 1 661 807 Shulman John D Common Stock, par value $0.0001 per share
Oct 18, 2021 Buy 1 661 807 Shulman John D Warrant
May 11, 2021 Buy 50 000 Arnold Mitchell Stock Option (right to buy)
May 11, 2021 Buy 75 000 Gesek Andrew Stock Option (right to buy)
Apr 08, 2021 Buy 50 000 Walker Wayne Remell Stock Option (right to buy)
Apr 08, 2021 Buy 50 000 Bradley Greg Stock Options (right to buy)
Apr 08, 2021 Buy 50 000 Shulman John D Stock Option (right to buy)
Apr 08, 2021 Buy 50 000 Bernstein Bruce Stock Option (right to buy)
Apr 08, 2021 Buy 50 000 Silverman Joshua Stock Option (right to buy)
Mar 23, 2021 Buy 0 Metuchen Therapeutics, Llc
Feb 19, 2021 Buy 215 669 Boctor Fady Stock Options (right to buy)
Dec 01, 2020 Buy 3 395 964 Shulman John D Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 0 Shulman John D Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 97 Gesek Andrew Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 975 Lavan Keith Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 3 382 416 Shulman John D Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 33 400 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 30 000 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 24 855 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 20 000 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 20 000 Silverman Joshua Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 2 000 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 1 875 Silverman Joshua Employee Stock Option (right to buy)
Dec 01, 2020 Buy 0 Bernstein Bruce Common Stock, par value $0.0001 per share
Dec 01, 2020 Buy 1 563 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 3 107 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 5 000 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 2 000 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 14 500 Bernstein Bruce Employee Stock Option (right to buy)
Dec 01, 2020 Buy 0 Gesek Andrew
Dec 01, 2020 Buy 0 Bradley Greg
Dec 01, 2020 Buy 0 Walker Wayne Remell
Dec 01, 2020 Buy 0 Lavan Keith
Dec 01, 2020 Buy 0 Silverman Joshua
Dec 01, 2020 Buy 0 Boctor Fady
Dec 01, 2020 Buy 0 Shulman John D Common Stock, par value $0.0001 per share
Jan 19, 2020 Buy 0 Arnold Mitchell Common Stock, par value $0.0001 per share
Jan 19, 2020 Buy 0 Arnold Mitchell Common Stock, par value $0.0001 per share
INSIDER POWER
73.112
Last 83 transactions
Buy: 12 810 318 | Sell: 34 179 (Shares)

Based on the 83 latest insides trades, we have calculated the insider power to be positive at a ratio of 73.112.

In total, the insiders bought 12 810 318 and sold 34 179 PTPI shares in the last 83 trades.

Click to get the best stock tips daily for free!

About Petros Pharmaceuticals Inc

Petros Pharmaceuticals Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vac... PTPI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT